Bilaketaren emaitzak - Anne‐Marie C. Dingemans

Findu emaitzak
  1. 1
    Heat shock protein antagonists in early stage clinical trials for NSCLC

    Heat shock protein antagonists in early stage clinical trials for NSCLC nork Lizza Hendriks, Anne‐Marie C. Dingemans

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm

    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm nork Thierry Berghmans, Anne‐Marie C. Dingemans, Lizza Hendriks, J. Cadranel

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept

    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept nork Thierry Berghmans, Valérie Durieux, Lizza Hendriks, Anne‐Marie C. Dingemans

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer

    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer nork Wouter van Elmpt, Michel Öllers, Anne‐Marie C. Dingemans, Philippe Lambin, Dirk De Ruysscher

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer

    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer nork Jih‐Hsiang Lee, Johannes Voortman, Anne‐Marie C. Dingemans, Donna Voeller, Trung C. Pham, Yisong Wang, Giuseppe Giaccone

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Management of stage I and II nonsmall cell lung cancer

    Management of stage I and II nonsmall cell lung cancer nork Fiona McDonald, Michèle De Waele, Lizza Hendriks, Corinne Faivre‐Finn, Anne‐Marie C. Dingemans, Paul Van Schil

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management

    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management nork Jules L. Derks, Noémie Leblay, Sylvie Lantuéjoul, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Lynnette Fernández-Cuesta

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review

    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review nork Lizza Hendriks, B.C.M. Hermans, M.H.J. van den Beuken-van Everdingen, Monique Hochstenbag, Anne‐Marie C. Dingemans

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients

    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients nork Steven Petit, Wouter J. C. van Elmpt, Cary Oberije, Erik Vegt, Anne‐Marie C. Dingemans, Philippe Lambin, André Dekker, Dirk De Ruysscher

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer nork Anne‐Marie C. Dingemans, Vivian van den Boogaart, Bettine A.H. Vosse, Robert‐Jan van Suylen, Arjan W. Griffioen, Victor L. Thijssen

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC

    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC nork Karin J.C. Sanders, Lizza Hendriks, Esther G.C. Troost, Gerben Bootsma, Ruud Houben, Annemie M.W.J. Schols, Anne‐Marie C. Dingemans

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review

    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review nork Niccolò Giaj-Levra, Matteo Giaj Levra, Valérie Durieux, Silvia Novello, Benjamin Besse, Baktiar Hasan, Lizza Hendriks, Antonin Lévy, Anne‐Marie C. Dingemans, Thierry Berghmans

    Argitaratua 2019
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study nork Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? nork Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans, Cornelis van Kuijk, Michel Öllers, Dirk De Ruysscher, Pieter E. Postmus, Egbert F. Smit

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) nork Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia

    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia nork Celine M. Op den Kamp, Ramon Langen, Frank J. M. Snepvangers, Chiel C. de Theije, Johanna M Schellekens, Fabian Laugs, Anne‐Marie C. Dingemans, Annemie Schols

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer

    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer nork Angela van Baardwijk, S. Wanders, Liesbeth Boersma, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Philippe Lambin, Dirk De Ruysscher

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?

    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? nork Jules L. Derks, Anne‐Marie C. Dingemans, Robert‐Jan van Suylen, Michael A. den Bakker, Ronald Damhuis, Esther C. van den Broek, Ernst‐Jan Speel, Erik Thunnissen

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy

    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy nork Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stéphanie Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system

    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome sy... nork Celine M. Op den Kamp, Ramon Langen, Ronnie Minnaard, Marco Kelders, Frank J. M. Snepvangers, M. K.C. Hesselink, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: